Skip to content

Effect of oral administration of traditional Chinese medicine for promoting blood circulation and removing blood stasis plus Enema on fertility after tubal pregnancy

Effect of oral administration of traditional Chinese medicine for promoting blood circulation and removing blood stasis plus Enema on fertility after tubal pregnancy

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2022000053
Enrollment
Unknown
Registered
2022-06-21
Start date
2022-08-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ectopic pregnancy

Interventions

Control group:Postoperative symptomatic treatment
Treatment group:Oral and enema therapy with traditional Chinese medicine for promoting blood circulation and removing blood stasis

Sponsors

Wangjing hospital, Chinese Academy of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1) It meets the diagnostic criteria of fallopian tube pregnancy in western medicine and blood stasis syndrome in traditional Chinese medicine. (2) Patients aged 20-40 years after laparoscopic conservative surgery.

Exclusion criteria

Exclusion criteria: (1) Those aged 40 years, with serious diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system, and psychotic patients. (2) Congenital tubal malformation. (3) Tubal pregnancy with intrauterine pregnancy, ectopic pregnancy without tubal pregnancy, and postoperative persistent ectopic pregnancy. (4) Patients who require resection or ligation of bilateral fallopian tubes for various reasons. (5) Allergic constitution or allergy to known drugs in the study prescription. (6) Those who do not meet the inclusion criteria, have poor compliance, cannot judge the efficacy or have incomplete data.

Design outcomes

Primary

MeasureTime frame
Human chorionic gonadotropin;Tubal patency;

Countries

CHINA

Contacts

Public ContactCHENGLING
chengling2208@163.com13601382208

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026